Okay, well then I know you're probably someone who's using it for diabetes and I can ask more questions down that line
It can be difficult to tell the difference between expected appetite changes and concerning behaviors with GLP-1 use
indeed, anybody who decides to lose weight by more conventional means does exactly the same
In New Jersey, more than 30 plaintiffs have now petitioned for multicounty litigation in Middlesex County over claims that Ozempic and Wegovy caused permanent vision loss resulting from non-arteritic anterior ischemic optic neuropathy, or NAION
Probiotics, such as Bacteroides fragilis, have demonstrated in animal models to reverse ASD-like behaviors, and some clinicians report improvements in children with gastrointestinal issues
Semaglutide: A Proven GLP-1 Option Semaglutide, the active ingredient in Wegovy and Ozempic, is a GLP-1 receptor agonist specifically approved by the FDA for chronic weight management